Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CXCL11/I-TAC Mouse anti-Human, Clone: B-S40, Novus Biologicals™
  7. NB160254

CXCL11/I-TAC Mouse anti-Human, Clone: B-S40, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP318117500UL

 View more versions of this product

Catalog No. NB160254


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

CXCL11/I-TAC Monoclonal antibody specifically detects CXCL11/I-TAC in Human samples. It is validated for ELISA
Specifications

Specifications

CXCL11/I-TAC
Monoclonal
1 mg/ml
ELISA
Beta-R1, b-R1, chemokine (C-X-C motif) ligand 11, H174IP9, Interferon gamma-inducible protein 9, Interferon-inducible T-cell alpha chemoattractant, IP-9member 11, ITAC, I-TACMGC102770, small inducible cytokine subfamily B (Cys-X-Cys), member 9B, Small-inducible cytokine B11
Recombinant human CXCL11/I-TAC. Hybridoma: Myeloma X63/AG.8653 x Balb/c node cells
500 μg
Biologically Active Proteins, Chemokines and Cytokines, Cytokine Research
6373
Store at 4C short term. Aliquot and store at -70C long term. Avoid freeze-thaw cycles.
IgG1 κ
ELISA
B-S40
Unconjugated
PBS. Sterile-filtered through 0.22 um.
Mouse
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.